14-day Premium Trial Subscription Sign Up For FreeGet Free

Eyegate Pharmaceuticals Stock Forecast NASDAQ:EYEG

$2.04 (4.62%)

Volume: 1M

Closed: Oct 19, 2021

Hollow Logo Score: 1.411

Eyegate Pharmaceuticals Stock Forecast

$2.04 (4.62%)

Volume: 1M

Closed: Oct 19, 2021

Score Hollow Logo 1.411

Eyegate Pharmaceuticals Stock Price (Quote) NASDAQ:EYEG

$2.04 ( 4.62% ) Tuesday, 19th Oct 2021

Range Low Price High Price Comment
30 days $1.73 $2.34 Tuesday, 19th Oct 2021 EYEG stock ended at $2.04. This is 4.62% more than the trading day before Monday, 18th Oct 2021. During the day the stock fluctuated 8.90% from a day low at $1.91 to a day high of $2.08.
90 days $1.44 $6.43
52 weeks $1.44 $8.18

Historical Eyegate Pharmaceuticals prices

Date Open High Low Close Volume
2021-10-19 $1.94 $2.08 $1.91 $2.04 1 062 881
2021-10-18 $1.93 $1.97 $1.90 $1.95 533 155
2021-10-15 $2.06 $2.06 $1.93 $1.94 808 014
2021-10-14 $2.06 $2.12 $2.01 $2.04 758 737
2021-10-13 $1.95 $2.07 $1.93 $2.06 1 680 679
2021-10-12 $1.96 $2.03 $1.91 $1.97 1 140 768
2021-10-11 $1.85 $1.98 $1.84 $1.90 1 157 972
2021-10-08 $1.84 $1.88 $1.82 $1.85 769 966
2021-10-07 $1.80 $1.95 $1.80 $1.86 1 921 155
2021-10-06 $1.79 $1.84 $1.73 $1.79 1 245 755
2021-10-05 $1.85 $1.92 $1.78 $1.81 2 004 040
2021-10-04 $2.01 $2.14 $1.78 $1.82 2 763 885
2021-10-01 $2.11 $2.30 $2.01 $2.02 3 470 622
2021-09-30 $1.86 $2.34 $1.83 $2.25 14 242 059
2021-09-29 $1.92 $1.94 $1.76 $1.83 2 331 894
2021-09-28 $1.94 $1.98 $1.86 $1.91 1 225 831
2021-09-27 $1.97 $2.02 $1.92 $1.93 1 373 449
2021-09-24 $2.00 $2.04 $1.87 $1.91 1 828 001
2021-09-23 $1.79 $2.13 $1.79 $2.10 4 897 189
2021-09-22 $1.86 $1.88 $1.77 $1.83 1 367 234
2021-09-21 $1.79 $1.88 $1.79 $1.82 948 527
2021-09-20 $1.85 $1.95 $1.76 $1.79 2 042 974
2021-09-17 $1.90 $2.02 $1.73 $2.00 3 670 290
2021-09-16 $1.95 $2.04 $1.83 $1.90 3 285 275
2021-09-15 $1.80 $1.99 $1.75 $1.95 5 507 807
2021-09-14 $1.76 $1.85 $1.71 $1.80 2 767 500
2021-09-13 $1.61 $1.77 $1.58 $1.68 1 553 353
2021-09-10 $1.60 $1.67 $1.57 $1.63 855 143
2021-09-09 $1.60 $1.64 $1.57 $1.61 866 154
2021-09-08 $1.76 $1.78 $1.57 $1.59 2 291 919
2021-09-07 $1.74 $1.87 $1.74 $1.75 1 570 710
2021-09-03 $1.81 $1.82 $1.72 $1.75 627 532
2021-09-02 $1.81 $1.81 $1.74 $1.78 854 158
2021-09-01 $1.88 $1.93 $1.78 $1.85 1 276 034
2021-08-31 $1.72 $1.87 $1.69 $1.84 2 029 790
2021-08-30 $1.69 $1.79 $1.62 $1.69 1 617 785
2021-08-27 $1.58 $1.68 $1.56 $1.68 776 841
2021-08-26 $1.68 $1.71 $1.55 $1.56 998 563
2021-08-25 $1.70 $1.73 $1.63 $1.69 916 066
2021-08-24 $1.61 $1.75 $1.57 $1.70 1 349 996
2021-08-23 $1.56 $1.65 $1.55 $1.62 921 815
2021-08-20 $1.50 $1.56 $1.49 $1.52 725 840
2021-08-19 $1.50 $1.63 $1.47 $1.48 2 121 554
2021-08-18 $1.56 $1.59 $1.44 $1.52 2 462 067
2021-08-17 $1.58 $1.74 $1.48 $1.64 4 664 350
2021-08-16 $1.63 $1.65 $1.45 $1.58 1 110 469
2021-08-13 $1.70 $1.72 $1.62 $1.63 814 369
2021-08-12 $1.77 $1.80 $1.68 $1.73 538 438
2021-08-11 $1.83 $1.83 $1.70 $1.78 1 002 393
2021-08-10 $1.82 $1.89 $1.73 $1.81 6 158 543

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials in anterior uveitis for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of th... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT